{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:50:29Z","timestamp":1791827429478,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR055686"],"award-info":[{"award-number":["R01AR055686"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K01AR077686"],"award-info":[{"award-number":["K01AR077686"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P50HD105328"],"award-info":[{"award-number":["P50HD105328"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2022R1C1C1006721"],"award-info":[{"award-number":["2022R1C1C1006721"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015499","name":"Jeonbuk National University","doi-asserted-by":"publisher","award":["54896"],"award-info":[{"award-number":["54896"]}],"id":[{"id":"10.13039\/501100015499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016988","name":"Biomedical Research Institute, Jeonbuk National University Hospital","doi-asserted-by":"publisher","award":["54907"],"award-info":[{"award-number":["54907"]}],"id":[{"id":"10.13039\/100016988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dysferlinopathy (Limb Girdle Muscular Dystrophy R2\/LGMD2B) causes progressive weakness of limb-girdle muscles. Although gait abnormalities are common, the contribution of spinal muscles to disease symptoms remains poorly understood. Using cross-sectional MRI in patients and longitudinal analyses in a dysferlinopathic mouse model, we identify early-onset, progressive adipogenic degeneration of spinal muscles as a previously unrecognized hallmark of dysferlinopathy. Multiple spinal muscles, including the iliocostalis, longissimus, and spinalis, are affected, with degeneration preceding pathology in limb muscles. In mice, early spinal muscle loss is associated with altered posture and gait, implicating axial muscle degeneration as a functional driver of disease. Mechanistically, spinal muscle degeneration is accompanied by an intrinsic increase in adipogenic differentiation of spinal fibroadipogenic progenitors (FAPs). Transcriptomic profiling implicated HDAC and Wnt\/\u00df-catenin signaling as the main regulators of FAP adipogenic shift. Pharmacological inhibition of either pathway suppressed adipogenic differentiation of dysferlinopathic FAPs in vitro, with in vivo inhibition of GSK3 reducing adipogenic degeneration in spinal and injured limb muscles. These findings establish early spinal muscle degeneration as a key pathological feature of dysferlinopathy and identify GSK3 signaling as a promising therapeutic target.<\/jats:p>","DOI":"10.1038\/s44321-026-00514-5","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:41:45Z","timestamp":1791819705000},"page":"4034-4058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FAP adipogenesis drives early spinal muscle loss in dysferlinopathy and reveals a therapeutic target"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-7618","authenticated-orcid":false,"given":"Young Jae","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7454-3732","authenticated-orcid":false,"given":"Nikki","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8018-7819","authenticated-orcid":false,"given":"Thomas","family":"Diehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Staedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C","family":"Bittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-7051","authenticated-orcid":false,"given":"Paul C","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sik","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4054-2838","authenticated-orcid":false,"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ackermann-Bonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5992-5185","authenticated-orcid":false,"given":"Jyoti K","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"514_CR1","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1194\/jlr.RA119000399","volume":"60","author":"AK Agarwal","year":"2019","unstructured":"Agarwal AK, Tunison K, Mitsche MA, McDonald JG, Garg A (2019) Insights into lipid accumulation in skeletal muscle in dysferlin-deficient mice. J Lipid Res 60:2057\u20132073","journal-title":"J Lipid Res"},{"issue":"Suppl 2","key":"514_CR2","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1016\/j.nmd.2012.05.011","volume":"22","author":"A Alejaldre","year":"2012","unstructured":"Alejaldre A, Diaz-Manera J, Ravaglia S, Tibaldi EC, D\u2019Amore F, Moris G, Muelas N, Vilchez JJ, Garcia-Medina A, Uson M et al (2012) Trunk muscle involvement in late-onset Pompe disease: study of thirty patients. Neuromuscul Disord 22(Suppl 2):S148\u2013S154","journal-title":"Neuromuscul Disord"},{"key":"514_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mus.27523","volume":"65","author":"R Alvarez-Velasco","year":"2022","unstructured":"Alvarez-Velasco R, Nunez-Peralta CA, Alonso-Perez J, Gallardo E, Collet-Vidiella R, Reyes-Leiva D, Pascual-Goni E, Martin-Aguilar L, Caballero-Avila M, Carbayo-Viejo A et al (2022) High prevalence of paraspinal muscle involvement in adults with McArdle disease. Muscle Nerve 65:568\u2013573","journal-title":"Muscle Nerve"},{"key":"514_CR4","first-page":"207","volume":"39","author":"C Angelini","year":"2020","unstructured":"Angelini C (2020) LGMD. Identification, description and classification. Acta Myol 39:207\u2013217","journal-title":"Acta Myol"},{"key":"514_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.792364","volume":"14","author":"SM Arciniegas Ruiz","year":"2021","unstructured":"Arciniegas Ruiz SM, Eldar-Finkelman H (2021) Glycogen synthase kinase-3 inhibitors: preclinical and clinical focus on CNS-A decade onward. Front Mol Neurosci 14:792364","journal-title":"Front Mol Neurosci"},{"key":"514_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.100992","volume":"39","author":"DP Bagchi","year":"2020","unstructured":"Bagchi DP, Li Z, Corsa CA, Hardij J, Mori H, Learman BS, Lewis KT, Schill RL, Romanelli SM, MacDougald OA (2020a) Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction. Mol Metab 39:100992","journal-title":"Mol Metab"},{"key":"514_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101078","volume":"42","author":"DP Bagchi","year":"2020","unstructured":"Bagchi DP, Nishii A, Li Z, DelProposto JB, Corsa CA, Mori H, Hardij J, Learman BS, Lumeng CN, MacDougald OA (2020b) Wnt\/beta-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells. Mol Metab 42:101078","journal-title":"Mol Metab"},{"key":"514_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"514_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature01573","volume":"423","author":"D Bansal","year":"2003","unstructured":"Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423:168\u2013172","journal-title":"Nature"},{"key":"514_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00415-019-09539-y","volume":"267","author":"A Barp","year":"2020","unstructured":"Barp A, Laforet P, Bello L, Tasca G, Vissing J, Monforte M, Ricci E, Choumert A, Stojkovic T, Malfatti E et al (2020) European muscle MRI study in limb girdle muscular dystrophy type R1\/2A (LGMDR1\/LGMD2A). J Neurol 267:45\u201356","journal-title":"J Neurol"},{"key":"514_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/1689","volume":"20","author":"R Bashir","year":"1998","unstructured":"Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z et al (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 20:37\u201342","journal-title":"Nat Genet"},{"key":"514_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jsp2.1079","volume":"3","author":"DB Berry","year":"2020","unstructured":"Berry DB, Rodriguez-Soto AE, Englund EK, Shahidi B, Parra C, Frank LR, Kelly KR, Ward SR (2020) Multiparametric MRI characterization of level dependent differences in lumbar muscle size, quality, and microstructure. JOR Spine 3:e1079","journal-title":"JOR Spine"},{"key":"514_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","volume":"26","author":"P Bettica","year":"2016","unstructured":"Bettica P, Petrini S, D\u2019Oria V, D\u2019Amico A, Catteruccia M, Pane M, Sivo S, Magri F, Brajkovic S, Messina S et al (2016) Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul Disord 26:643\u2013649","journal-title":"Neuromuscul Disord"},{"key":"514_CR14","doi-asserted-by":"publisher","first-page":"e141295","DOI":"10.1172\/JCI141295","volume":"132","author":"DC Bittel","year":"2022","unstructured":"Bittel DC, Sreetama SC, Chandra G, Ziegler R, Nagaraju K, Van der Meulen JH, Jaiswal JK (2022) Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B. J Clin Invest 132:e141295","journal-title":"J Clin Invest"},{"key":"514_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nmd.2023.11.004","volume":"34","author":"C Bolano-Diaz","year":"2024","unstructured":"Bolano-Diaz C, Verdu-Diaz J, Gonzalez-Chamorro A, Fitzsimmons S, Veeranki G, Straub V, Diaz-Manera J (2024) Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseases. Neuromuscul Disord 34:54\u201360","journal-title":"Neuromuscul Disord"},{"key":"514_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200283","volume":"11","author":"Bolano-Diaz","year":"2025","unstructured":"Bolano-Diaz, Reyngoudt CF, Wilson H, James IJ, Smith MK, Caldas de Almeida Araujo FE, Gordish-Dressman E, Hilsden H, Rufibach LE H, Wallace D et al (2025) Modeling of dysferlinopathy (LGMDR2) progression: a longitudinal fat fraction analysis. Neurol Genet 11:e200283","journal-title":"Neurol Genet"},{"key":"514_CR17","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.3390\/jcm12186011","volume":"12","author":"C Bouchard","year":"2023","unstructured":"Bouchard C, Tremblay JP (2023) Portrait of dysferlinopathy: diagnosis and development of therapy. J Clin Med 12:6011","journal-title":"J Clin Med"},{"key":"514_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4103\/aian.aian_987_24","volume":"28","author":"T Chawla","year":"2025","unstructured":"Chawla T, Baskar D, Polavarapu K, Preethish-Kumar V, Nashi S, Vengalil S, Kulanthaivelu K, Saini J, Huddar A, Unnikrishnan G et al (2025) Muscle MRI pattern in dysferlinopathy and its correlation with dysferlin gait. Ann Indian Acad Neurol 28:182\u2013188","journal-title":"Ann Indian Acad Neurol"},{"key":"514_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2119\/molmed.2013.00011","volume":"19","author":"S Consalvi","year":"2013","unstructured":"Consalvi S, Mozzetta C, Bettica P, Germani M, Fiorentini F, Del Bene F, Rocchetti M, Leoni F, Monzani V, Mascagni P et al (2013) Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol Med 19:79\u201387","journal-title":"Mol Med"},{"key":"514_CR20","doi-asserted-by":"publisher","first-page":"jcs232157","DOI":"10.1242\/jcs.232157","volume":"132","author":"O Contreras","year":"2019","unstructured":"Contreras O, Cruz-Soca M, Theret M, Soliman H, Tung LW, Groppa E, Rossi FM, Brandan E (2019) Cross-talk between TGF-beta and PDGFRalpha signaling pathways regulates the fate of stromal fibro-adipogenic progenitors. J Cell Sci 132:jcs232157","journal-title":"J Cell Sci"},{"key":"514_CR21","doi-asserted-by":"crossref","unstructured":"Cramer GD, Darby SA, Huff TG, Cummings SA, Mensching R, Sistak K, ScienceDirect (2014) Clinical anatomy of the spine, spinal cord, and ANS. Elsevier, St. Louis","DOI":"10.1016\/B978-0-323-07954-9.00003-7"},{"key":"514_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.627429","volume":"9","author":"TJJ de Winter","year":"2021","unstructured":"de Winter TJJ, Nusse R (2021) Running against the Wnt: how Wnt\/beta-catenin suppresses adipogenesis. Front Cell Dev Biol 9:627429","journal-title":"Front Cell Dev Biol"},{"key":"514_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.272","volume":"5","author":"A Defour","year":"2014","unstructured":"Defour A, Van der Meulen JH, Bhat R, Bigot A, Bashir R, Nagaraju K, Jaiswal JK (2014) Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion. Cell Death Dis 5:e1306","journal-title":"Cell Death Dis"},{"key":"514_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mus.25045","volume":"54","author":"J D\u00edaz","year":"2016","unstructured":"D\u00edaz J, Woudt L, Suazo L, Garrido C, Caviedes P, C\u00c1rdenas AM, Castiglioni C, Bevilacqua JA (2016) Broadening the imaging phenotype of dysferlinopathy at different disease stages. Muscle Nerve 54:203\u2013210","journal-title":"Muscle Nerve"},{"key":"514_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp-2017-317488","volume":"89","author":"J Diaz-Manera","year":"2018","unstructured":"Diaz-Manera J, Fernandez-Torron RJLL, James MK, Mayhew A, Smith FE, Moore UR, Blamire AM, Carlier PG, Rufibach L et al (2018) Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials. J Neurol Neurosurg Psychiatry 89:1071\u20131081","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"514_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"514_CR27","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, Kaller M (2016) MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32:3047\u20133048","journal-title":"Bioinformatics"},{"key":"514_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-2990.2002.00417.x","volume":"28","author":"M Fanin","year":"2002","unstructured":"Fanin M, Angelini C (2002) Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 28:461\u2013470","journal-title":"Neuropathol Appl Neurobiol"},{"key":"514_CR29","doi-asserted-by":"crossref","unstructured":"Fu Z, Wang T, Zhang C, Qi T, Chen Y, Yang J, Yang H, Yan B, Gong B, Lu W, Luo S, Liu Y, Sun L, Jiang H, Chen B, Zhang Z, Liu X, Wang Y (2026) Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3\u03b2 inhibition or AAV-mediated GMPPB gene replacement. Nat Commun 17:5340","DOI":"10.1038\/s41467-026-71524-7"},{"key":"514_CR30","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1212\/WNL.57.11.2136","volume":"57","author":"E Gallardo","year":"2001","unstructured":"Gallardo E, Rojas-Garcia R, de Luna N, Pou A, Brown RH Jr, Illa I (2001) Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 57:2136\u20132138","journal-title":"Neurology"},{"key":"514_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000336265","volume":"67","author":"I Gati","year":"2012","unstructured":"Gati I, Danielsson O, Gunnarsson C, Vrethem M, Haggqvist B, Fredriksson BA, Landtblom AM (2012) Bent spine syndrome: a phenotype of dysferlinopathy or a symptomatic DYSF gene mutation carrier. Eur Neurol 67:300\u2013302","journal-title":"Eur Neurol"},{"key":"514_CR32","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.ajpath.2014.02.005","volume":"184","author":"MD Grounds","year":"2014","unstructured":"Grounds MD, Terrill JR, Radley-Crabb HG, Robertson T, Papadimitriou J, Spuler S, Shavlakadze T (2014) Lipid accumulation in dysferlin-deficient muscles. Am J Pathol 184:1668\u20131676","journal-title":"Am J Pathol"},{"key":"514_CR33","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.ymthe.2017.06.025","volume":"25","author":"LV Gushchina","year":"2017","unstructured":"Gushchina LV, Bhattacharya S, McElhanon KE, Choi JH, Manring H, Beck EX, Alloush J, Weisleder N (2017) Treatment with recombinant human MG53 protein increases membrane integrity in a mouse model of limb girdle muscular dystrophy 2B. Mol Ther 25:2360\u20132371","journal-title":"Mol Ther"},{"key":"514_CR34","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.1074\/jbc.M109.081679","volume":"285","author":"M Haberland","year":"2010","unstructured":"Haberland M, Carrer M, Mokalled MH, Montgomery RL, Olson EN (2010) Redundant control of adipogenesis by histone deacetylases 1 and 2. J Biol Chem 285:14663\u201314670","journal-title":"J Biol Chem"},{"key":"514_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ar.21090","volume":"293","author":"B Hesse","year":"2010","unstructured":"Hesse B, Fischer MS, Schilling N (2010) Distribution pattern of muscle fiber types in the perivertebral musculature of two different sized species of mice. Anat Rec 293:446\u2013463","journal-title":"Anat Rec"},{"key":"514_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ana.10080","volume":"51","author":"M Ho","year":"2002","unstructured":"Ho M, Gallardo E, McKenna-Yasek D, De Luna N, Illa I, Brown RH Jr (2002) A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Ann Neurol 51:129\u2013133","journal-title":"Ann Neurol"},{"key":"514_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10438-z","volume":"10","author":"MW Hogarth","year":"2019","unstructured":"Hogarth MW, Defour A, Lazarski C, Gallardo E, Diaz Manera J, Partridge TA, Nagaraju K, Jaiswal JK (2019) Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nat Commun 10:2430","journal-title":"Nat Commun"},{"key":"514_CR38","first-page":"221436022412985","volume":"12","author":"MW Hogarth","year":"2025","unstructured":"Hogarth MW, Kurukunda MP, Ismat K, Uapinyoying P, Jaiswal JK (2025) Exploring the therapeutic potential of fibroadipogenic progenitors in muscle disease. J Neuromuscul Dis 12:22143602241298545","journal-title":"J Neuromuscul Dis"},{"key":"514_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molmed.2021.10.003","volume":"28","author":"MW Hogarth","year":"2022","unstructured":"Hogarth MW, Uapinyoying P, Mazala DAG, Jaiswal JK (2022) Pathogenic role and therapeutic potential of fibro-adipogenic progenitors in muscle disease. Trends Mol Med 28:8\u201311","journal-title":"Trends Mol Med"},{"key":"514_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nmd.2013.02.004","volume":"23","author":"MA Hornsey","year":"2013","unstructured":"Hornsey MA, Laval SH, Barresi R, Lochmuller H, Bushby K (2013) Muscular dystrophy in dysferlin-deficient mouse models. Neuromuscul Disord 23:377\u2013387","journal-title":"Neuromuscul Disord"},{"key":"514_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","volume":"112","author":"J Horrigan","year":"2020","unstructured":"Horrigan J, Gomes TB, Snape M, Nikolenko N, McMorn A, Evans S, Yaroshinsky A, Della Pasqua O, Oosterholt S, Lochmuller H (2020) A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1). Pediatr Neurol 112:84\u201393","journal-title":"Pediatr Neurol"},{"key":"514_CR42","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002) Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172\u20131183","journal-title":"Mol Cell Biol"},{"key":"514_CR43","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00415-010-5858-z","volume":"258","author":"B Jordan","year":"2011","unstructured":"Jordan B, Eger K, Koesling S, Zierz S (2011) Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol 258:866\u2013873","journal-title":"J Neurol"},{"key":"514_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.nmd.2009.02.005","volume":"19","author":"H Jungbluth","year":"2009","unstructured":"Jungbluth H, Lillis S, Zhou H, Abbs S, Sewry C, Swash M, Muntoni F (2009) Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 19:344\u2013347","journal-title":"Neuromuscul Disord"},{"key":"514_CR45","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/diagnostics10080530","volume":"10","author":"DH Kim","year":"2020","unstructured":"Kim DH, Jang DH, Jang JH (2020) Incidental severe fatty degeneration of the erector spinae in a patient with L5-S1 disc extrusion diagnosed with limb-girdle muscular dystrophy R2 dysferin-related. Diagnostics 10:530","journal-title":"Diagnostics"},{"key":"514_CR46","doi-asserted-by":"publisher","first-page":"18851","DOI":"10.1074\/jbc.M312795200","volume":"279","author":"DC Lagace","year":"2004","unstructured":"Lagace DC, Nachtigal MW (2004) Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. J Biol Chem 279:18851\u201318860","journal-title":"J Biol Chem"},{"key":"514_CR47","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","volume":"21","author":"G Lagger","year":"2002","unstructured":"Lagger G, O\u2019Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T et al (2002) Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21:2672\u20132681","journal-title":"EMBO J"},{"key":"514_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323","journal-title":"BMC Bioinformatics"},{"key":"514_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1:417\u2013425","journal-title":"Cell Syst"},{"key":"514_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/1682","volume":"20","author":"J Liu","year":"1998","unstructured":"Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB et al (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:31\u201336","journal-title":"Nat Genet"},{"key":"514_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.nmd.2023.02.007","volume":"33","author":"L Llanso","year":"2023","unstructured":"Llanso L, Moore U, Bolano-Diaz C, James M, Blamire AM, Carlier PG, Rufibach L, Gordish-Dressman H, Boyle G, Hilsden H et al (2023) Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern. Neuromuscul Disord 33:349\u2013357","journal-title":"Neuromuscul Disord"},{"key":"514_CR52","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-012-6817-7","volume":"260","author":"S Loseth","year":"2013","unstructured":"Loseth S, Voermans NC, Torbergsen T, Lillis S, Jonsrud C, Lindal S, Kamsteeg EJ, Lammens M, Broman M, Dekomien G et al (2013) A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J Neurol 260:1504\u20131510","journal-title":"J Neurol"},{"key":"514_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"514_CR54","doi-asserted-by":"publisher","first-page":"17489","DOI":"10.18632\/aging.203238","volume":"13","author":"X Lv","year":"2021","unstructured":"Lv X, Qiu J, Hao T, Zhang H, Jiang H, Tan Y (2021) HDAC inhibitor Trichostatin A suppresses adipogenesis in 3T3-L1 preadipocytes. Aging 13:17489\u201317498","journal-title":"Aging"},{"key":"514_CR55","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0960-8966(00)00157-7","volume":"11","author":"I Mahjneh","year":"2001","unstructured":"Mahjneh I, Marconi G, Bushby K, Anderson LV, Tolvanen-Mahjneh H, Somer H (2001) Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations. Neuromuscul Disord 11:20\u201326","journal-title":"Neuromuscul Disord"},{"key":"514_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53886-y","volume":"15","author":"BM Marcella","year":"2024","unstructured":"Marcella BM, Hockey BL, Braun JL, Whitley KC, Geromella MS, Baranowski RW, Watson CJF, Silvera S, Hamstra SI, Wasilewicz LJ et al (2024) GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy. Nat Commun 15:10210","journal-title":"Nat Commun"},{"key":"514_CR57","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1111\/febs.12261","volume":"280","author":"A Mariano","year":"2013","unstructured":"Mariano A, Henning A, Han R (2013) Dysferlin-deficient muscular dystrophy and innate immune activation. FEBS J 280:4165\u20134176","journal-title":"FEBS J"},{"key":"514_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jmri.20804","volume":"25","author":"E Mercuri","year":"2007","unstructured":"Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F (2007) Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 25:433\u2013440","journal-title":"J Magn Reson Imaging"},{"key":"514_CR59","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","volume":"23","author":"E Mercuri","year":"2024","unstructured":"Mercuri E, Vilchez JJ, Boespflug-Tanguy O, Zaidman CM, Mah JK, Goemans N, Muller-Felber W, Niks EH, Schara-Schmidt U, Bertini E et al (2024) Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 23:393\u2013403","journal-title":"Lancet Neurol"},{"key":"514_CR60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1468-1331.2010.03240.x","volume":"18","author":"M Meznaric","year":"2011","unstructured":"Meznaric M, Gonzalez-Quereda L, Gallardo E, de Luna N, Gallano P, Fanin M, Angelini C, Peterlin B, Zidar J (2011) Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele. Eur J Neurol 18:1021\u20131023","journal-title":"Eur J Neurol"},{"key":"514_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0174-5","volume":"9","author":"M Milan","year":"2018","unstructured":"Milan M, Pace V, Maiullari F, Chirivi M, Baci D, Maiullari S, Madaro L, Maccari S, Stati T, Marano G et al (2018) Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation. Cell Death Dis 9:108","journal-title":"Cell Death Dis"},{"key":"514_CR62","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm1479","volume":"12","author":"GC Minetti","year":"2006","unstructured":"Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M et al (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12:1147\u20131150","journal-title":"Nat Med"},{"key":"514_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.613446","volume":"11","author":"U Moore","year":"2020","unstructured":"Moore U, Jacobs M, Fernandez-Torron RJLLR, Smith FE, James M, Mayhew A, Rufibach L, Carlier PG, Blamire AM et al (2020) Intensive teenage activity is associated with greater muscle hyperintensity on T1W magnetic resonance imaging in adults with dysferlinopathy. Front Neurol 11:613446","journal-title":"Front Neurol"},{"key":"514_CR64","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.molmed.2024.01.007","volume":"30","author":"C Mozzetta","year":"2024","unstructured":"Mozzetta C, Sartorelli V, Steinkuhler C, Puri PL (2024) HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients. Trends Mol Med 30:278\u2013294","journal-title":"Trends Mol Med"},{"key":"514_CR65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1440-1789.2004.00573.x","volume":"24","author":"T Nagashima","year":"2004","unstructured":"Nagashima T, Chuma T, Mano Y, Goto Y, Hayashi YK, Minami N, Nishino I, Nonaka I, Takahashi T, Sawa H et al (2004) Dysferlinopathy associated with rigid spine syndrome. Neuropathology 24:341\u2013346","journal-title":"Neuropathology"},{"key":"514_CR66","doi-asserted-by":"publisher","first-page":"e13173","DOI":"10.14814\/phy2.13173","volume":"5","author":"N Nagy","year":"2017","unstructured":"Nagy N, Nonneman RJ, Llanga T, Dial CF, Riddick NV, Hampton T, Moy SS, Lehtimaki KK, Ahtoniemi T, Puolivali J et al (2017) Hip region muscular dystrophy and emergence of motor deficits in dysferlin-deficient Bla\/J mice. Physiol Rep 5:e13173","journal-title":"Physiol Rep"},{"key":"514_CR67","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/hum.2017.062","volume":"29","author":"RA Potter","year":"2018","unstructured":"Potter RA, Griffin DA, Sondergaard PC, Johnson RW, Pozsgai ER, Heller KN, Peterson EL, Lehtimaki KK, Windish HP, Mittal PJ et al (2018) Systemic delivery of dysferlin overlap vectors provides long-term gene expression and functional improvement for dysferlinopathy. Hum Gene Ther 29:749\u2013762","journal-title":"Hum Gene Ther"},{"key":"514_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.9","volume":"2","author":"M Pryadkina","year":"2015","unstructured":"Pryadkina M, Lostal W, Bourg N, Charton K, Roudaut C, Hirsch ML, Richard I (2015) A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence. Mol Ther Methods Clin Dev 2:15009","journal-title":"Mol Ther Methods Clin Dev"},{"key":"514_CR69","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1113\/JP285103","volume":"602","author":"CJ Quinn","year":"2024","unstructured":"Quinn CJ, Cartwright EJ, Trafford AW, Dibb KM (2024) On the role of dysferlin in striated muscle: membrane repair, t-tubules and Ca(2+) handling. J Physiol 602:1893\u20131910","journal-title":"J Physiol"},{"key":"514_CR70","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/biom13101536","volume":"13","author":"A Rawls","year":"2023","unstructured":"Rawls A, Diviak BK, Smith CI, Severson GW, Acosta SA, Wilson-Rawls J (2023) Pharmacotherapeutic approaches to treatment of muscular dystrophies. Biomolecules 13:1536","journal-title":"Biomolecules"},{"key":"514_CR71","doi-asserted-by":"publisher","first-page":"dmm049915","DOI":"10.1242\/dmm.049915","volume":"16","author":"A Reggio","year":"2023","unstructured":"Reggio A, De Paolis F, Bousselmi S, Cicciarelli F, Bernardini S, Rainer A, Seliktar D, Testa S, Cirillo C, Grumati P et al (2023) A 3D adipogenesis platform to study the fate of fibro\/adipogenic progenitors in muscular dystrophies. Dis Model Mech 16:dmm049915","journal-title":"Dis Model Mech"},{"key":"514_CR72","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1038\/s41418-020-0551-y","volume":"27","author":"A Reggio","year":"2020","unstructured":"Reggio A, Rosina M, Palma A, Cerquone Perpetuini A, Petrilli LL, Gargioli C, Fuoco C, Micarelli E, Giuliani G, Cerretani M et al (2020) Adipogenesis of skeletal muscle fibro\/adipogenic progenitors is affected by the WNT5a\/GSK3\/beta-catenin axis. Cell Death Differ 27:2921\u20132941","journal-title":"Cell Death Differ"},{"key":"514_CR73","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.289.5481.950","volume":"289","author":"SE Ross","year":"2000","unstructured":"Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950\u2013953","journal-title":"Science"},{"key":"514_CR74","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/stem.170237","volume":"17","author":"ML Rothenberg","year":"1999","unstructured":"Rothenberg ML, Nelson AR, Hande KR (1999) New drugs on the horizon: matrix metalloproteinase inhibitors. Stem Cells 17:237\u2013240","journal-title":"Stem Cells"},{"issue":"Suppl 2","key":"514_CR75","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.nmd.2012.05.012","volume":"22","author":"A Sarkozy","year":"2012","unstructured":"Sarkozy A, Deschauer M, Carlier RY, Schrank B, Seeger J, Walter MC, Schoser B, Reilich P, Leturq F, Radunovic A et al (2012) Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord 22(Suppl 2):S122\u2013S129","journal-title":"Neuromuscul Disord"},{"key":"514_CR76","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1469-7580.2012.01517.x","volume":"221","author":"MD Schuenke","year":"2012","unstructured":"Schuenke MD, Vleeming A, Van Hoof T, Willard FH (2012) A description of the lumbar interfascial triangle and its relation with the lateral raphe: anatomical constituents of load transfer through the lateral margin of the thoracolumbar fascia. J Anat 221:568\u2013576","journal-title":"J Anat"},{"key":"514_CR77","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1212\/WNL.56.11.1472","volume":"56","author":"D Selcen","year":"2001","unstructured":"Selcen D, Stilling G, Engel AG (2001) The earliest pathologic alterations in dysferlinopathy. Neurology 56:1472\u20131481","journal-title":"Neurology"},{"key":"514_CR78","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mus.20910","volume":"37","author":"P Seror","year":"2008","unstructured":"Seror P, Krahn M, Laforet P, Leturcq F, Maisonobe T (2008) Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy. Muscle Nerve 37:410\u2013414","journal-title":"Muscle Nerve"},{"key":"514_CR79","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"96","author":"M Shtutman","year":"1999","unstructured":"Shtutman M, Zhurinsky J, Simcha I, Albanese C, D\u2019Amico M, Pestell R, Ben-Ze\u2019ev A (1999) The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522\u20135527","journal-title":"Proc Natl Acad Sci USA"},{"key":"514_CR80","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/acn3.50801","volume":"6","author":"AMS Silva","year":"2019","unstructured":"Silva AMS, Coimbra-Neto AR, Souza PVS, Winckler PB, Goncalves MVM, Cavalcanti EBU, Carvalho A, Sobreira C, Camelo CG, Mendonca RDH et al (2019) Clinical and molecular findings in a cohort of ANO5-related myopathy. Ann Clin Transl Neurol 6:1225\u20131238","journal-title":"Ann Clin Transl Neurol"},{"key":"514_CR81","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.ymthe.2018.07.021","volume":"26","author":"SC Sreetama","year":"2018","unstructured":"Sreetama SC, Chandra G, Van der Meulen JH, Ahmad MM, Suzuki P, Bhuvanendran S, Nagaraju K, Hoffman EP, Jaiswal JK (2018) Membrane stabilization by modified steroid offers a potential therapy for muscular dystrophy due to dysferlin deficit. Mol Ther 26:2231\u20132242","journal-title":"Mol Ther"},{"key":"514_CR82","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","volume":"28","author":"V Straub","year":"2018","unstructured":"Straub V, Murphy A, Udd B (2018) 229th ENMC international workshop: limb girdle muscular dystrophies-nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord 28:702\u2013710","journal-title":"Neuromuscul Disord"},{"key":"514_CR83","first-page":"831","volume":"4","author":"E Telles","year":"2012","unstructured":"Telles E, Seto E (2012) Modulation of cell cycle regulators by HDACs. Front Biosci 4:831\u2013839","journal-title":"Front Biosci"},{"key":"514_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103667","volume":"25","author":"K Tominaga","year":"2022","unstructured":"Tominaga K, Tominaga N, Williams EO, Rufibach L, Schowel V, Spuler S, Viswanathan M, Guarente LP (2022) 4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations. iScience 25:103667","journal-title":"iScience"},{"key":"514_CR85","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.3748\/wjg.v23.i25.4480","volume":"23","author":"M Triki","year":"2017","unstructured":"Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R (2017) Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol 23:4480\u20134490","journal-title":"World J Gastroenterol"},{"key":"514_CR86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ncb2014","volume":"12","author":"A Uezumi","year":"2010","unstructured":"Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K (2010) Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 12:143\u2013152","journal-title":"Nat Cell Biol"},{"key":"514_CR87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3920\/CEP150008","volume":"11","author":"S Valentin","year":"2015","unstructured":"Valentin S, Licka TF (2015) Comparative need for spinal stabilisation between quadrupedal and bipedal locomotion. Comp Exerc Physiol 11:95\u2013105","journal-title":"Comp Exerc Physiol"},{"key":"514_CR88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M van de Wetering","year":"2002","unstructured":"van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP et al (2002) The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241\u2013250","journal-title":"Cell"},{"key":"514_CR89","doi-asserted-by":"publisher","first-page":"13642","DOI":"10.1074\/jbc.271.23.13642","volume":"271","author":"C Vaziri","year":"1996","unstructured":"Vaziri C, Faller DV (1996) Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts. J Biol Chem 271:13642\u201313648","journal-title":"J Biol Chem"},{"key":"514_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-26","volume":"8","author":"MC Walter","year":"2013","unstructured":"Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, Muller-Reible C, Vorgerd M, Urban P et al (2013) Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis 8:26","journal-title":"Orphanet J Rare Dis"},{"key":"514_CR91","doi-asserted-by":"publisher","first-page":"e00155","DOI":"10.1128\/MCB.00155-19","volume":"39","author":"M Wang","year":"2019","unstructured":"Wang M, Weng WC, Stock L, Lindquist D, Martinez A, Gourdon G, Timchenko N, Snape M, Timchenko L (2019) Correction of glycogen synthase kinase 3beta in myotonic dystrophy 1 reduces the mutant RNA and improves postnatal survival of DMSXL mice. Mol Cell Biol 39:e00155\u201319","journal-title":"Mol Cell Biol"},{"key":"514_CR92","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jbiomech.2008.09.042","volume":"42","author":"SR Ward","year":"2009","unstructured":"Ward SR, Tomiya A, Regev GJ, Thacker BE, Benzl RC, Kim CW, Lieber RL (2009) Passive mechanical properties of the lumbar multifidus muscle support its role as a stabilizer. J Biomech 42:1384\u20131389","journal-title":"J Biomech"},{"key":"514_CR93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awv332","volume":"139","author":"N Witting","year":"2016","unstructured":"Witting N, Andersen LK, Vissing J (2016) Axial myopathy: an overlooked feature of muscle diseases. Brain 139:13\u201322","journal-title":"Brain"},{"key":"514_CR94","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.devcel.2018.06.018","volume":"46","author":"MN Wosczyna","year":"2018","unstructured":"Wosczyna MN, Rando TA (2018) A muscle stem cell support group: coordinated cellular responses in muscle regeneration. Dev Cell 46:135\u2013143","journal-title":"Dev Cell"},{"key":"514_CR95","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4161\/adip.21916","volume":"2","author":"Z Xu","year":"2013","unstructured":"Xu Z, Ande SR, Mishra S (2013) Temporal analysis of protein lysine acetylation during adipocyte differentiation. Adipocyte 2:33\u201340","journal-title":"Adipocyte"},{"key":"514_CR96","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s42255-023-00813-y","volume":"5","author":"Z Yang Loureiro","year":"2023","unstructured":"Yang Loureiro Z, Joyce S, DeSouza T, Solivan-Rivera J, Desai A, Skritakis P, Yang Q, Ziegler R, Zhong D, Nguyen TT et al (2023) Wnt signaling preserves progenitor cell multipotency during adipose tissue development. Nat Metab 5:1014\u20131028","journal-title":"Nat Metab"},{"key":"514_CR97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40478-022-01473-x","volume":"11","author":"J Yasa","year":"2023","unstructured":"Yasa J, Reed CE, Bournazos AM, Evesson FJ, Pang I, Graham ME, Wark JR, Nijagal B, Kwan KH, Kwiatkowski T et al (2023) Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice. Acta Neuropathol Commun 11:15","journal-title":"Acta Neuropathol Commun"},{"key":"514_CR98","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"514_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133639","volume":"275","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wang E, Li Q, Peng Y, Jin H, Naseem S, Sun B, Park S, Choi S, Li X (2024) GSK3 regulation Wnt\/beta-catenin signaling affects adipogenesis in bovine skeletal muscle fibro\/adipogenic progenitors. Int J Biol Macromol 275:133639","journal-title":"Int J Biol Macromol"},{"key":"514_CR100","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1177\/03635465251319549","volume":"53","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhou M, Zhu Y, Xie J, Huo Z, Zhang D, Li P, Guo J, Li G, Li X et al (2025) The glycogen synthase kinase-3 inhibitor CHIR99021 reduces fatty infiltration and muscle atrophy after rotator cuff tears: an in vitro experiment and in vivo mouse model. Am J Sports Med 53:1184\u20131194","journal-title":"Am J Sports Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00514-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:24:55Z","timestamp":1791825895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00514-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":100,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,12]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00514-5","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors JKJ and MWH hold US Patent #12,594,278, which is related to the work reported here. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}